Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System for Creating Hemodialysis Vascular Access (NCT06712251)

🧪 Interventions in This Study

• Velocity pAVF System (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (5 Sites)

• Trinity Research Group — Dothan, Alabama
• Apex Research — Riverside, California
• American Access Care of Jacksonville — Jacksonville, Florida
• Texas Research Institute — Fort Worth, Texas
• STAR Vascular — San Antonio, Texas

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Chronic Kidney Disease Requiring Hemodialysis

• DIALysis With EXpanded Solute Removal — London, Ontario
• Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients — Albuquerque, New Mexico

Explore by condition: All Chronic Kidney Disease Requiring Hemodialysis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.